Although it has been plagued by multiple issues, including falling sales with lower demand for its Covid-19 products, and an ...

The at-home test kits are designed to detect current COVID-19 variants, and can be used through the end of this year.

Pfizer stock (NYSE: PFE) is trading at about $30 per share, not far from the lows seen in recent years. Could the stock rise by over 2x in value over the next few years? Does this sound a bit ...

Updated rapid tests are expected to be able to detect newer variants just as a new COVID variant arrives in Michigan.

Flu season is rapidly approaching, and COVID has not gone away. As more and more people are getting sick this time of year, ...

Free at-home COVID-19 tests are now available for families across the nation. As of Thursday, families are now able to obtain ...

A federal judge in Washington D.C. cited the government’s “general immunity” in dismissing a lawsuit that accused the ...

A federal judge has dismissed a lawsuit by a New York family who claimed the Department of Defense misled Americans into ...

Pfizer has so far signed up less than a quarter of the countries targeted under a plan to make its medicines available to the ...

Pfizer's decision late on Wednesday to withdraw its sickle cell disease treatment due to the risk of death could help speed ...

Analyst Evan Seigerman of BMO Capital maintained a Buy rating on Pfizer (PFE – Research Report), retaining the price target of $36.00.